Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Processa has signed an agreement with Aposense to license in the patent rights to develop and commercialize their next generation irinotecan cancer drug, ATT-11T.
read more
Themis and Merck announced the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire privately-held Themis.
read more
Apotex is voluntarily recalling all lots of Metformin Hydrochloride Extended-Release Tablets, USP 500mg within expiry to retail level.
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
HemaCare has expanded its portfolio of GMP-compliant cellular material with the launch of the GMPrime cryopreserved leukopak.
read more
The companies are coming together to form a coalition to accomplish their shared goal of bringing promising cancer therapies to patients.
read more
Octapharma and BioMatrix Specialty Pharmacy are supporting a new study focused on treating patients with COVID-19 and presenting with COVID-19-associated myocardial dysfunction.
read more
Orbita has secured $9 million of venture funding as part of the company's Series A financing round.
read more
I-MED Pharma is collaborating with KMG International Limited to manufacture and supply PPE and COVID-19 diagnostic tests.
read more
Almac Group has received a $288,000 grant to support a clinical study in Sub-Saharan Africa in efforts to find a treatment for Coronavirus.
read more
Lonza Sanquin Reagents have entered into a strategic partnership for the commercialization of a range of specialized reagents for pyrogen testing of parenteral pharmaceuticals and medical devices using the Monocyte Activation Test.
read more
Ajinomoto Bio-Pharma Services has completed the acquisition of Granules OmniChem Private, purchasing the remaining 50 percent ownership interest from Granules India.
read more
Centinel Spine® announced FDA approval for the manufacturing transfer of both the prodisc® C Cervical Total Disc Replacement and prodisc® L Lumbar Total Disc Replacement systems to new vendors.
read more
Rentschler Biopharma has entered into a collaboration with Genmab for the development and manufacture of bispecific antibodies generated with Genmab’s DuoBody technology platform.
read more
CordenPharma announced the signing of an amendment to their existing manufacturing agreement with Moderna, a clinical stage biotechnology company.
read more